Follow LF0 researchXLinkedInSubstackFacebook
tput: No value for $TERM and no -T specified

Research

Amgen (AMGN) Stock Analysis & Research

Latest rating
Hold
Latest report
Oct 23, 2026
Reports
1
Sector
Healthcare

Amgen Inc. discovers, develops, manufactures and sells human therapeutics, with revenue driven by global product sales to wholesalers, providers and pharmacies.

Backtesting dashboard with equity curve and drawdown analysis
Quantitative market report dashboard with factor and risk analysis
SEC filing comparison with highlighted document changes